Abstract

BackgroundGenetic and environmental factors play a significant role in systemic sclerosis (SSc). African Americans are known for a higher SSc incidence, an earlier age of onset, and a greater frequency...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.
...
Rheumatology (Oxford, England) | VOL. 59
, et. al. ...
04 Nov 2019
Health disparities in regional anesthesia and analgesia for the management of acute pain in trauma patients.
Adam J Milam ... Rodney A Gabriel
International anesthesiology clinics | VOL. 61
Adam J Milam, et. al.Adam J Milam ... Rodney A Gabriel
18 Nov 2022
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis.
Muzaffar H Qazilbash ... Sheeba K Thomas
American journal of hematology | VOL. 96
Muzaffar H Qazilbash, et. al.Muzaffar H Qazilbash ... Sheeba K Thomas
04 Oct 2021
Ethical Considerations Regarding the Use of Race in Pulmonary Function Testing
Jeremy Sugarman ... Meredith C Mccormack
Chest | VOL. 162
Jeremy Sugarman, et. al.Jeremy Sugarman ... Meredith C Mccormack
01 Oct 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers